Nepal | January 19, 2021

As India readies vaccine strategy, Modi warns of possible side-effects

Share Now:

NEW DELHI: Indian Prime Minister Narendra Modi warned on Tuesday that any COVID-19 vaccine could lead to side-effects in some people, as even popular medicines do, and that the government would only go by science in finalising one for the country.

The comments came ahead of the possible launch of the Oxford-AstraZeneca vaccine by early next year in India, the country with the world’s second-highest number of coronavirus infections after the United States.

The question of who pays any claims for damages for unexpected side-effects has been a tricky point in supply negotiations between countries and drug makers over potential vaccines. Some richer countries have agreed full or partial exemptions from liability for firms to secure shots.

Indian officials have not commented on who would be held responsible if any vaccine led to serious unwanted consequences. Brazil has said it will not exempt vaccine makers from liability, but Mexico could share some of the burden with laboratories.

Modi said both speed and safety were equally important in launching a vaccine, but that, once established scientific processes had determined the right path, India would follow it.

“Even medicines popular for 20 years and used by hundreds of thousands of people lead to reactions in some, even today,” Modi said in a video conference with state chief ministers.

“It’s possible with vaccines too. Any decision on them should only be weighed on a scientific scale. Whatever vaccine makes it through the world’s certified processes, we will have to accept them and move ahead.”

Modi said it was not yet known which vaccine would be launched in India and at what price, but urged states to work with the federal government to keep distribution infrastructure such as cold storages ready.

After the AstraZeneca vaccine’s third-stage trial results were revealed on Monday, its Indian manufacturer the Serum Institute of India said it would first focus on supplying its home market in the next few months.

The other experimental vaccines on trial in India are the government and Bharat Biotch’s COVAXIN; Russia’s Sputnik-V; Zydus Cadila’s ZyCoV-D and lastly one that Biological E. Ltd is developing with Baylor College of Medicine and Dynavax Technologies Corp.

India on Tuesday recorded 37,975 new infections, taking the total to 9.18 million. Deaths rose by 480, with the total now at 134,218.


Follow The Himalayan Times on Twitter and Facebook

Recommended Stories:

More from The Himalayan Times:

PM has no right to dissolve House, SC told

KATHMANDU, JANUARY 17 Lawyers representing the petitioners that have challenged the dissolution of the House of Representatives today began pleading before the constitutional bench of the Supreme Court led by Chief Justice Cholendra Shumsher JB Rana. Advocate Bhimarjun Acharya said the prime m Read More...

EC consults parties regarding snap polls

KATHMANDU, JANUARY 17 The Election Commission today held consultation with 11 political parties on midterm polls announced for April 30 and May 10. EC Spokesperson Raj Kumar Shrestha said Chief Election Commissioner Dinesh Kumar Thapaliya informed representatives of political parties about its Read More...

Valley schools reopening after 10 months

KATHMANDU, JANUARY 17 Schools across all local bodies inside Kathmandu valley have started reopening. They had been closed for at least 10 months due to the COVID-19 pandemic. On March 24, the government imposed a blanket lockdown in a bid to subdue the spread of coronavirus, which hit the Read More...

Double for Stones as Man City crush Palace to go second

MANCHESTER: Manchester City steamed into second place in the Premier League with defender John Stones scoring an unlikely double in a 4-0 demolition of visiting Crystal Palace on Sunday. Central defender Stones, closing in on 100 Premier League appearances for City, headed his first league g Read More...

Information Technology

Smart diplomacy: Needs tech-driven approach

A calling need for tech-savviness in state diplomacy with a tech-managed system has assumed diplomatic importance to promote techno-economic cooperation and trade promotion. Technical knowledge about economic and trade connections with both the developed and emerging countries would substantially he Read More...

EDITORIAL: Unresolved issues

It would be in the best interest of both Nepal and India to resolve the boundary issue amicably Foreign Minister Pradeep Gyawali returned home on Saturday after wrapping up his three-day visit to India, where he took part in the sixth Foreign Minister-Level Joint Commission meeting. But he could no Read More...

THT logo

P is for patience

Grief, like a violent storm, has a span. While a storm usually spends itself after an hour or two, leaving behind a trail of devastation, the intensity of grief does not peter out that quick. It lasts for several months, in some cases for years. In most such instances, one doesn’t really know how Read More...

15 held in connection with Thapa’s murder

NEPALGUNJ, JANUARY 17 Police arrested 15 persons in relation to the murder of assistant informant Prabin Thapa working at National Investigation Department, Banke. Police started an investigation taking into custody the girl Thapa was in love with. Police have not disclosed the girl’s name. Read More...